共 97 条
[91]
Thornton, P.S., Alter, C.A., Levin Katz, L.E., Short and long term use of octreotide in the treatment of congenital hyperinsulinism (1993) Pediatrics, 123, pp. 637-643
[92]
Lamberts, S.W.J., Pieters, G.F.F.M., Metselaar, H.J., Ong, G.L., Tan, H.S., Reubi, J.C., Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours (1988) Acta Endocrinol, 119, pp. 561-566
[93]
Sassolas, G., The role of sandostatin in acromegaly (1992) Metabolism, 41, pp. 39-43
[94]
Dowling, R.H., Hussaini, S.H., Murphy, G.M., Besser, G.M., Wass, J.A.H., Gallstones during octreotide therapy (1992) Metabolism, 41, pp. 22-33
[95]
Creutzfeldt, W., Lembeke, B., Folsch, U.R., Schleser, S., Koop, I., Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans (1987) Am J Med, 82, pp. 9-59
[96]
Londong, W., Angerer, M., Kutz, K., Landgraf, R., Londong, V., Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration (1989) Gastroenterology, 96, pp. 713-722
[97]
Patel, Y.C., Greenwood, M.T., Warszynska, A., Panetta, R., Srikant, C.B., All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase (1994) Biochem Biophys Res Commun, 198, pp. 605-612